Alla studier
RekryteringOBSERVATIONELL

ECD-Score: a Study on Erdheim-Chester Disease

This study focuses on Erdheim-Chester Disease (ECD), a very rare condition where certain immune cells build up in different parts of the body. Because it's so rare, there are still many unanswered questions about how it affects people over time, including survival and everyday abilities. Doctors currently lack a good way to predict these long-term outcomes accurately. This research hopes to create a new scoring system, called an ECD-Score, that can combine important information about a patient's disease. This score would help healthcare teams understand better what to expect for each individual and allow for more tailored care, ultimately aiming to improve the lives of people living with ECD.

Överblick

Status
Rekrytering
Sponsor
Meyer Children's Hospital IRCCS
Inskrivningsmål
1,000
Starta
23 dec 2024
Beräknad slutförande
01 dec 2028

Vad handlar denna studie om?

Erdheim-Chester Disease (ECD) is a very rare condition that affects the body's immune system. In ECD, certain immune cells called histiocytes, which normally help fight infections, start to grow abnormally and build up in different parts of the body. This can happen in bones, around organs like the kidneys, in the heart, brain, or even the gland that controls hormones (pituitary gland). Because these cells can appear in so many places, the symptoms and how it affects each person can be very different, from mild to quite serious.

Doctors know that ECD is often caused by a specific change (mutation) in certain genes, which makes these immune cells behave differently. This can lead to ongoing inflammation and damage to the affected body parts. Despite growing knowledge about ECD in recent years, especially considering how few people have it, there are still many gaps in understanding. For example, it's hard for doctors to predict how the disease will progress for an individual patient over many years, including how it might affect their survival or their daily life and abilities.

This study aims to help fill these gaps. Currently, it's challenging for doctors to get a full picture of how ECD affects a patient's life, including things like their day-to-day abilities, mood, and thinking. This research wants to develop a new tool, called an 'ECD-Score'. This score would bring together different pieces of information about a patient's disease to give doctors a clearer idea of what might happen in the long term. This improved understanding will help doctors and patients make better decisions about care and hopefully lead to better quality of life for those with ECD.

Viktiga punkter

  • This study focuses on a rare immune system condition called Erdheim-Chester Disease (ECD).
  • Its main goal is to create a new scoring system to predict how ECD might affect patients in the long term.
  • The study will use existing medical records, not new treatments or tests.
  • Better predictions could lead to more personalised care and improved quality of life.
  • Participation involves allowing researchers to use your anonymous historical medical data.
  • This research tackles a gap in understanding due to ECD's rarity.

Vem kan vara berättigad?

To be considered for this study, you would first need to be diagnosed with Erdheim-Chester Disease (ECD) according to the most up-to-date medical guidelines. This diagnosis needs to be confirmed by your doctor.

Also, the researchers would need to be able to access your medical information, such as details about your diagnosis, any genetic tests you've had, treatments you've received, and how you responded to those treatments. They would also need to have at least one year's worth of follow-up information about your condition.

People would not be able to join the study if they don't have a confirmed diagnosis or enough information from their medical history. Also, if a patient or, for children, their parent or legal guardian, is unable or unwilling to give their permission (informed consent) to take part, then they cannot be included in the study.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Do you have a confirmed diagnosis of Erdheim-Chester Disease (ECD)?
  2. Are your doctors able to share your full medical history for ECD, including treatments and how successful they were?
  3. Do your medical records show at least one year of follow-up since your ECD diagnosis?
  4. Are you, or your parent/guardian if you are under 18, willing and able to give permission for your anonymous data to be used?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

This study is primarily looking at existing medical records and information from people who have already been diagnosed with and treated for Erdheim-Chester Disease. This means that if you participate, you would not typically need to attend extra hospital visits, take new medication related to the study, or undergo additional tests. The researchers will be collecting and analysing information that has already been gathered as part of your routine medical care for ECD. The total duration of your involvement would be based on the availability of your past medical records, specifically needing records that cover at least one year of follow-up after your diagnosis. You would also need to provide your informed consent to allow your de-identified data to be used for this research.

Potentiella risker och fördelar

The main benefit of taking part in this study is that the information gathered will help researchers develop a better way to understand and predict the long-term effects of Erdheim-Chester Disease. This could lead to improved care and a better quality of life for future patients with ECD. Since this study primarily uses existing medical records, the direct risks to you are very low, as you won't undergo new procedures or treatments specifically for the research. Your personal information will be kept confidential and used anonymously. Remember, you have the right to withdraw your consent at any time without affecting your medical care.

Platser (7)

  • National Institute of Health
    Verifierat postnummer
    Bethesda, USA· Rekryterar inte ännu
  • Mayo Clinic
    Verifierat postnummer
    Rochester, USA· Rekryterar inte ännu
  • Memorial Sloan Kettering Cancer Center
    Verifierat postnummer
    New York, USA· Rekryterar inte ännu
  • Hopital Pitiè-Salpetriere
    Verifierat postnummer
    Paris, Frankrike· Rekryterar inte ännu
  • Meyer Children's Hospital IRCCS, Firenze
    Verifierat postnummer
    Florens, Italien· Rekrytering
  • San Raffaele Hospital
    Verifierat postnummer
    Milano, Italien· Rekryterar inte ännu
  • Newcastle Upon Tyne Hospitals NHS Foundation Trust
    Verifierat postnummer
    Newcastle, Storbritannien· Rekryterar inte ännu

Vanliga frågor

What is Erdheim-Chester Disease (ECD)?

ECD is a very rare condition where certain immune cells build up in different body parts, like bones or organs, potentially causing problems and symptoms.

Vad försöker studien uppnå?

This study aims to create an 'ECD-Score' to help doctors better predict how the disease will progress and its long-term effects on patients.

Will I have to take new medicines or have extra tests?

No, this study mainly uses existing medical records, so you won't need new treatments or extra tests as part of the research.

How will this study help people with ECD?

By creating a better prediction tool, it can help doctors create more personalised treatment plans and improve the quality of life for people with ECD.

Vad händer om jag ändrar mig angående att delta?

You can withdraw your consent to participate at any time, and this will not affect your medical care.

Hur du får reda på mer

Augusto Vaglio, Medical Doctor

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "ECD-Score: a Study on Erdheim-Chester Disease…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.